https://ars-853inhibitor.com/a....pplication-of-normal
The purchase times of CE-CCMRA and DS-CCTA, respectively, were 9.5 ± 3.1 min and 8.3 ± 1.4 s. On patient-based evaluation, the sensitiveness, specificity, negative and positive predictive value of CE-CCMRA and DS-CCTA were 93.5% versus 93.5%(P 0.05), 85% versus 90%(P 0.05), 90.6% versus 93.5%(P 0.05), and 89.4% versus 90%(P 0.05), respectively. The region under the bend (AUC) was 0.89 (95% CI 0.79 to 0.99) for CE-CCMRA and 0.92 (95% CI 0.83 to 1.0 for DS-CCTA
Like
Comment
Share
